Inactive Instrument

TVAX BIOM Share Price

Equities

US87306M1099

Biotechnology & Medical Research

End-of-day quote Nasdaq
- USD - Intraday chart for TVAX BIOM
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Managers TitleAgeSince
Founder 70 13/07/11
Founder 68 13/07/11
Founder 82 13/07/11
Members of the board TitleAgeSince
Founder 73 30/11/11
Founder 68 13/07/11
Director/Board Member 60 30/11/11
More insiders
TVAX Biomedical, Inc. is a clinical-stage development company advancing its targeted cell-based immunotherapy for the treatment of cancer. The Company offers immunotherapeutic cancer treatment platform for various types of cancers. The Company's lead candidate is TVI-Brain-1, which is used for the treatment of brain cancer and targets glioblastomas. The Company has completed Phase II trials for TVI-Brain-1. The Company's other candidate is TVI-Kidney-1, which is used for the treatment of kidney cancer and targets stage 4 renal cell carcinoma. The Company has completed Phase II trials for TVI-Kidney-1. The Company's immunotherapeutic cancer treatment platform, TVAX Immunotherapy, is a personalized combination of cancer cell vaccination and killer T cell treatment platform. The Company's subsidiary, TVAX Animal Health, is focused on adapting the TVAX Immunotherapy for applications in the veterinary sector with a focus on cancer in dogs.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW